What is influencing a change in obesity rates in the United States
New CDC data shows obesity rates for adults maybe slowing, while childhood and teen rates hit record highs.
March 05, 2026
Denver7 talked to bariatric surgeon Dr. Katy Irani with HCA HealthONE Rose.
Learn more about Dr. Irani and the team at Denver Center for Weight Loss and Bariatric Surgery
Published:
March 05, 2026
Location:
HCA HealthONE Rose
Related Newsroom Articles
For weight loss, this intermittent fasting strategy beat out daily calorie counting
April 10, 2025
A new study found that a 4:3 intermittent fasting plan — with three days of fasting per week — helped people lose more weight than daily calorie counting.
Retatrutide is a new GLP-1 hit. But is it legal?
November 14, 2025
You've heard of the popular (GLP-1) receptor agonist drug semaglutide (Ozempic, Wegovy) and GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound), but there's a new kid on the block.
GLP-1s may offer better dementia protection than metformin
July 29, 2025
The International Diabetes Federation reports there were about 589 million adults around the world living with diabetes in 2024, with 90% of these having type 2 diabetes.
For weight loss, this intermittent fasting strategy beat out daily calorie counting
April 10, 2025
A new study found that a 4:3 intermittent fasting plan — with three days of fasting per week — helped people lose more weight than daily calorie counting.
Retatrutide is a new GLP-1 hit. But is it legal?
November 14, 2025
You've heard of the popular (GLP-1) receptor agonist drug semaglutide (Ozempic, Wegovy) and GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound), but there's a new kid on the block.
GLP-1s may offer better dementia protection than metformin
July 29, 2025
The International Diabetes Federation reports there were about 589 million adults around the world living with diabetes in 2024, with 90% of these having type 2 diabetes.
For weight loss, this intermittent fasting strategy beat out daily calorie counting
April 10, 2025
A new study found that a 4:3 intermittent fasting plan — with three days of fasting per week — helped people lose more weight than daily calorie counting.
Retatrutide is a new GLP-1 hit. But is it legal?
November 14, 2025
You've heard of the popular (GLP-1) receptor agonist drug semaglutide (Ozempic, Wegovy) and GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound), but there's a new kid on the block.
GLP-1s may offer better dementia protection than metformin
July 29, 2025
The International Diabetes Federation reports there were about 589 million adults around the world living with diabetes in 2024, with 90% of these having type 2 diabetes.
For weight loss, this intermittent fasting strategy beat out daily calorie counting
April 10, 2025
A new study found that a 4:3 intermittent fasting plan — with three days of fasting per week — helped people lose more weight than daily calorie counting.